Allergy Immunotherapy Market Outlook 2026–2030: Growth Trends, Market Dynamics And Emerging Opportunities
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Allergy Immunotherapy Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The allergy immunotherapy market has seen rapid expansion in its size over recent years. It is projected to grow from $3.16 billion in 2025 to $3.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.3%. The market’s growth during the historic period can be attributed to limited awareness about allergy immunotherapy, a rising incidence of seasonal allergic rhinitis, dependency on hospital-based treatment channels, the adoption of traditional treatment methods, and regulatory approvals for immunotherapy products.
The allergy immunotherapy market is projected for substantial expansion in the coming years, reaching $5.64 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This anticipated growth during the forecast period is driven by factors such as the rise of personalized immunotherapy solutions, increased adoption of online pharmacy channels, broader application of pediatric allergy treatments, growing investment in immunotherapy research, and the development of combination immunotherapy products. Major trends within the forecast period include the increasing uptake of subcutaneous and sublingual immunotherapy, a rising prevalence of allergic rhinitis and asthma, the expansion of treatments for food and venom allergies, an enhanced focus on tailored allergy treatment protocols, and improved awareness coupled with early diagnosis of allergic conditions.
Get A Free Sample Report With In-Depth Market Insights:
Allergy Immunotherapy Market Expansion Drivers: What’s Shaping Future Growth?
The increasing occurrence of allergic conditions is anticipated to drive the expansion of the allergy immunotherapy market. Allergic disorders are characterized by an excessive immune response to specific antigens, distinct from autoimmune diseases where the immune system attacks the body’s own components. Allergy immunotherapy is designed for atopic individuals grappling with conditions such as IgE-mediated allergic rhinitis and allergic asthma, which are provoked by inhaled allergens like pollens and house dust mites (HDMs). For illustration, the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK executive body, stated in August 2023 that English hospitals recorded over 25,000 admissions for allergies and anaphylaxis in 2022-23, a figure more than double that from the last twenty years. Additionally, the Food Standards Agency, a UK government department, revealed in May 2024 through its Patterns and Prevalence of Adult Food Allergy (PAFA) report that roughly 6% of adults in the UK, translating to approximately 2.4 million individuals, are affected by food allergies. Hence, the rising prevalence of allergic disorders is propelling the growth of the allergy immunotherapy market.
Allergy Immunotherapy Market Segment Breakdown: Which Categories Lead On Revenue?
The allergy immunotherapy market covered in this report is segmented –
1) By Allergy Type: Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, Allergic Conjunctivitis, Environmental Allergies
2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)
3) By Channel: Hospital Pharmacy, Retail Pharmacy
Subsegments:
1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis
2) By Allergic Asthma: House Dust Mite–Induced Allergic Asthma, Pollen-Induced Allergic Asthma, Animal Dander–Induced Allergic Asthma
3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies
4) By Venom Allergy: Bee Venom Allergy, Wasp Venom Allergy, Hornet Venom Allergy, Other Insect Venom Allergies
5) By Allergic Conjunctivitis: Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis
6) By Environmental Allergies: House Dust Mite Allergy, Pollen Allergy, Mold Allergy, Animal Dander Allergy
Allergy Immunotherapy Market Strategic Trends: What Defines The Next Growth Phase?
Major companies in the allergy immunotherapy market are innovating technological products, such as artificial intelligence (AI)-powered allergy component testing, to sustain their position. This AI-powered allergy component testing is a novel diagnostic platform based on component resolved diagnostics (CRD) for identifying various forms of allergies. For instance, in May 2023, Metropolis Healthcare Limited, an Indian medical laboratory company, launched artificial intelligence (AI)-powered allergy component testing. This technology represents a fourth-generation allergy testing method that utilizes Artificial Intelligence to assist clinicians in their clinical decision-making. It provides significant insights for selecting and optimizing the course of treatment for allergic diseases. Furthermore, it is capable of predicting the effectiveness of immunotherapy for allergy vaccinations.
Allergy Immunotherapy Market Leading Players And Competitive Positioning
Major companies operating in the allergy immunotherapy market are LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Mylan N.V., Adamis Pharmaceuticals Corporation, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.
View The Full Allergy Immunotherapy Market Report:
Allergy Immunotherapy Market Regional Analysis And Top Geography
Europe was the largest region in the allergy immunotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
